Search results for: Competition

Biosimilars’ Price Dynamic in Europe

30 June 2010

…and Partners. Publication now available for download: Mattison, N., Mestre-Ferrandiz, J. and Towse, A.  eds (2010) Biosimilars: How much entry and price competition will result? London: Office of Health Economics….

OHE Welcomes Dr. Aslam Anis

28 January 2015

…primary areas of expertise include Canadian competition policy in the pharmaceutical industry and the cost-effectiveness of treatments for HIV/AIDS and rheumatoid arthritis.    Dr. Anis’s research activities have been extensive….

OHE Lunchtime Seminar and Webinar with Professor David Grabowski: Interventions that Encourage High-Value Nursing Home Care: Lessons for the UK

21 March 2017

…explored the use of market mechanisms such as pay-for-performance and report cards to encourage quality competition. This lecture will offer a health economics perspective on how payment and delivery interventions…

The Market for Biosimilars: Evolution and Policy Options

1 November 2008

…and other payers also should encourage pharmacovigilance and other outcomes studies that produce the PSY data that will encourage interchangeability and greater price competition. Over time, biosimilar markets can become…

Foundation

…large but uncertain benefits.  They began to consider how payment mechanisms needed to adapt and also how to use competition as a useful lever for lower prices. This shift arose…

PharmaDiplomacy: A Proposal for a Collaborative, Mutually Acceptable Approach to Drug Pricing

5 October 2015, 11:00pm

…fair and objective assessment of their value, and competitive market forces should encourage price competition. In practice, of course, these remain highly challenging goals.  This lunchtime seminar will debate whether…

OHE Lunchtime Seminar: Interventions that Encourage High-Value Nursing Home Care: Lessons for the UK

18 April 2017, 11:00pm

…mechanism to encourage quality. Newer efforts have explored the use of market mechanisms such as pay-for-performance and report cards to encourage quality competition. This lecture will offer a health economics…

OHE Annual Lecture 2019: The Evolution of U.S. Policy Responses to the Opioid Epidemic

14 October 2019, 11:00pm

…and substance abuse care, long term care financing policy, health care competition and implementation of health reform and disability policy. He served as the deputy assistant secretary for planning and…

Personalised Medicine: Is it an Oil-Rush or Oil-Spill?

3 February 2020, 12:00am

…He has also acted as an advisor to a number of governments and governmental bodies (including the UK government, The UK Competition Commission (investigating private health care delivery in the…